Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study
- PMID: 10205100
- PMCID: PMC27832
- DOI: 10.1136/bmj.318.7190.1035
Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study
Abstract
Objectives: To investigate the effect of Chlamydia pneumoniae infection on future development of ischaemic heart disease and mortality.
Design: Prospective longitudinal study.
Setting: Caerphilly, South Wales.
Subjects: Plasma specimens were collected during 1979-83 from 1773 men aged 45-59 years. These were tested for IgG and IgA antibodies to C pneumoniae (TW183) by microimmunofluorescence.
Outcome measures: 13 year mortality and incident ischaemic heart disease events were ascertained from death certificates, hospital records, and electrocardiographic changes at follow up every 4 to 5 years.
Results: 642 men (36.2%) had IgG antibodies at a titre of >/=1 in 16, of whom 362 (20.4% of all men) also had detectable IgA antibodies. The prevalence of ischaemic heart disease (a history of past or current disease) at entry was similar at all IgG antibody titres but was positively related to IgA antibody titre. IgA antibody titre was positively correlated with plasma viscosity but not with other cardiovascular risk factors. Incidence of ischaemic heart disease was not associated with either IgG antibody titre or IgA antibody titre, but there were stronger and significant relations of IgA antibodies with all cause mortality and fatal ischaemic heart disease, which persisted after adjustment for conventional cardiovascular risk factors. The odds ratios associated with detectable IgA antibodies were 1.07 (95% confidence interval 0.75 to 1.53) for all incident ischaemic heart disease, 1. 83 (1.17 to 2.85) for fatal ischaemic heart disease, and 1.50 (1.10 to 2.04) for all cause mortality.
Conclusion: This is the first prospective demonstration of an association between IgA antibodies to C pneumoniae, a putative marker of chronic infection, and subsequent risk of death from ischaemic heart disease. In contrast to earlier case-control studies, IgG antibodies were not associated with either prevalent or incident ischaemic heart disease.
Comment in
-
Commentary: Chlamydia pneumoniae infection and ischaemic heart disease.BMJ. 1999 Apr 17;318(7190):1039-40. BMJ. 1999. PMID: 10336284 No abstract available.
-
Relation of C pneumoniae antibodies to ischaemic heart disease. Why were samples weakly positive for IgG antibodies not tested for IgA antibodies?BMJ. 1999 Dec 11;319(7224):1575. BMJ. 1999. PMID: 10591734 Free PMC article. No abstract available.
-
Relation of C pneumoniae antibodies to ischaemic heart disease. Finnish study finds significant association between raised IgG, but not IgA, titres and mortality.BMJ. 1999 Dec 11;319(7224):1575-6. BMJ. 1999. PMID: 10651478 No abstract available.
Similar articles
-
Relation of C pneumoniae antibodies to ischaemic heart disease. Finnish study finds significant association between raised IgG, but not IgA, titres and mortality.BMJ. 1999 Dec 11;319(7224):1575-6. BMJ. 1999. PMID: 10651478 No abstract available.
-
Relation of C pneumoniae antibodies to ischaemic heart disease. Why were samples weakly positive for IgG antibodies not tested for IgA antibodies?BMJ. 1999 Dec 11;319(7224):1575. BMJ. 1999. PMID: 10591734 Free PMC article. No abstract available.
-
Seroprevalence of Chlamydophila pneumoniae in ischaemic heart disease.New Microbiol. 2010 Oct;33(4):381-5. New Microbiol. 2010. PMID: 21213597
-
The prevalence of chronic Chlamydia pneumoniae infection as detected by polymerase chain reaction in pharyngeal samples from patients with ischaemic heart disease.Eur Heart J. 1998 Sep;19(9):1321-7. doi: 10.1053/euhj.1998.1010. Eur Heart J. 1998. PMID: 9792256 Clinical Trial.
-
Novel cardiovascular risk markers in women with ischaemic heart disease.Cardiovasc J Afr. 2014 May-Jun;25(3):137-41. doi: 10.5830/CVJA-2014-014. Cardiovasc J Afr. 2014. PMID: 25000444 Free PMC article. Review.
Cited by
-
Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis.Clin Diagn Lab Immunol. 2002 Mar;9(2):207-15. doi: 10.1128/cdli.9.2.207-215.2002. Clin Diagn Lab Immunol. 2002. PMID: 11874854 Free PMC article. Review. No abstract available.
-
Chlamydia pneumoniae and Cardiovascular Disease.Curr Infect Dis Rep. 2002 Feb;4(1):35-43. doi: 10.1007/s11908-002-0065-4. Curr Infect Dis Rep. 2002. PMID: 11853655
-
Prevention of coronary heart disease through treatment of infection with Chlamydia pneumoniae? Estimation of possible effectiveness and costs.Health Care Manag Sci. 2001 Dec;4(4):269-79. doi: 10.1023/a:1011838211092. Health Care Manag Sci. 2001. PMID: 11718459
-
Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study.BMJ. 2000 Jul 22;321(7255):204-7. doi: 10.1136/bmj.321.7255.204. BMJ. 2000. PMID: 10903649 Free PMC article.
-
Atherosclerosis Induced by Chlamydophila pneumoniae: A Controversial Theory.Interdiscip Perspect Infect Dis. 2013;2013:941392. doi: 10.1155/2013/941392. Epub 2013 Jul 17. Interdiscip Perspect Infect Dis. 2013. PMID: 23956742 Free PMC article.
References
-
- Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;ii:983–986. - PubMed
-
- Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430–436. - PubMed
-
- Kuo CC, Shor A, Fukushi H, Patton DL, Campbell LA, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841–847. - PubMed
-
- Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med. 1996;125:979–982. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous